1. Home
  2. FEMY vs FENG Comparison

FEMY vs FENG Comparison

Compare FEMY & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • FENG
  • Stock Information
  • Founded
  • FEMY 2004
  • FENG 1998
  • Country
  • FEMY United States
  • FENG China
  • Employees
  • FEMY N/A
  • FENG N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • FENG Broadcasting
  • Sector
  • FEMY Health Care
  • FENG Industrials
  • Exchange
  • FEMY Nasdaq
  • FENG Nasdaq
  • Market Cap
  • FEMY 29.9M
  • FENG 25.2M
  • IPO Year
  • FEMY 2021
  • FENG 2011
  • Fundamental
  • Price
  • FEMY $0.92
  • FENG $2.23
  • Analyst Decision
  • FEMY Strong Buy
  • FENG
  • Analyst Count
  • FEMY 3
  • FENG 0
  • Target Price
  • FEMY $8.67
  • FENG N/A
  • AVG Volume (30 Days)
  • FEMY 257.9K
  • FENG 7.9K
  • Earning Date
  • FEMY 08-07-2025
  • FENG 08-12-2025
  • Dividend Yield
  • FEMY N/A
  • FENG N/A
  • EPS Growth
  • FEMY N/A
  • FENG N/A
  • EPS
  • FEMY N/A
  • FENG N/A
  • Revenue
  • FEMY $1,699,232.00
  • FENG $97,280,369.00
  • Revenue This Year
  • FEMY $283.83
  • FENG N/A
  • Revenue Next Year
  • FEMY $161.03
  • FENG N/A
  • P/E Ratio
  • FEMY N/A
  • FENG N/A
  • Revenue Growth
  • FEMY 61.97
  • FENG 1.04
  • 52 Week Low
  • FEMY $0.69
  • FENG $1.28
  • 52 Week High
  • FEMY $1.80
  • FENG $4.01
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 46.22
  • FENG 57.81
  • Support Level
  • FEMY $0.91
  • FENG $2.17
  • Resistance Level
  • FEMY $0.99
  • FENG $2.35
  • Average True Range (ATR)
  • FEMY 0.05
  • FENG 0.14
  • MACD
  • FEMY 0.00
  • FENG 0.01
  • Stochastic Oscillator
  • FEMY 11.71
  • FENG 71.87

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

Share on Social Networks: